Meningococcal serogroup Y emergence in Europe: update 2011 - Wikidata - wikimedia - TriplyDB

Meningococcal serogroup Y emergence in Europe: update 2011

Meningococcal serogroup Y emergence in Europe: update 2011

http://www.wikidata.org/entity/Q28703551

about

Prevention of rare diseases: how revolutionary techniques can help vulnerable individuals-the example of serogroup B meningococcal infection Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013 Meningococcal serogroup Y emergence in Europe: high importance in some European regions in 2012.Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development.A decade of invasive meningococcal disease surveillance in Poland.Genome-Based Characterization of Emergent Invasive Neisseria meningitidis Serogroup Y Isolates in Sweden from 1995 to 2012.Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study A High-Throughput Size Exclusion Chromatography Method to Determine the Molecular Size Distribution of Meningococcal Polysaccharide Vaccine.Glycoconjugate vaccines: an update.Need for Optimisation of Immunisation Strategies Targeting Invasive Meningococcal Disease in the Netherlands.Persistent occurrence of serogroup Y/sequence type (ST)-23 complex invasive meningococcal disease among patients aged five to 14 years, Italy, 2007 to 2013.Changes in the Population Structure of Invasive Neisseria meningitidis in the United States After Quadrivalent Meningococcal Conjugate Vaccine Licensure.Meningococcal Quadrivalent Tetanus Toxoid Conjugate Vaccine (MenACWY-TT; Nimenrix®): A Review.

P2860

Q28080522-8BA687BA-839E-4EDA-A634-7F04826885DA Q28607725-C11A8572-DBA1-49B8-927C-DA508A93518E Q33577926-B83672F2-83B4-4DBB-83F5-EDB75BF40BA8 Q33743483-F74BB6F8-C52E-4A69-85E2-4AE72FF5FAAC Q34972731-ADA38A9F-4CED-4B1C-8D0C-D739981B2395 Q35757635-165D1995-C804-4033-A37B-1967FC688853 Q35826786-E0CECDB7-0270-4D33-9C38-9FE1730D27F6 Q37263960-2EB76C47-9BB6-4905-A7CC-142DEF59A95A Q38286346-F60C6C03-021E-4D2F-9D09-49C435B452ED Q38931495-13A3D0C7-2332-484C-9F8B-51EC7AFD0C4B Q40895395-8EAF40B5-97A3-42C6-8A43-BF3BE440FDD7 Q41565209-35A69A5E-AFE1-4450-819E-F3975774CA37 Q47672096-EB92E09C-FAC6-4C59-88BF-9BB601086D54

P2860

Meningococcal serogroup Y emergence in Europe: update 2011

http://www.wikidata.org/entity/Q28703551

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Meningococcal serogroup Y emergence in Europe: update 2011

@ast

Meningococcal serogroup Y emergence in Europe: update 2011

@en

Meningococcal serogroup Y emergence in Europe: update 2011

@nl

type

label

Meningococcal serogroup Y emergence in Europe: update 2011

@ast

Meningococcal serogroup Y emergence in Europe: update 2011

@en

Meningococcal serogroup Y emergence in Europe: update 2011

@nl

prefLabel

Meningococcal serogroup Y emergence in Europe: update 2011

@ast

Meningococcal serogroup Y emergence in Europe: update 2011

@en

Meningococcal serogroup Y emergence in Europe: update 2011

@nl

P1433

Q28703551-F2295622-C8A6-4480-AA2A-7029B6A29A8F

P1476

Q28703551-6B79AAF4-DBC3-470B-AA2F-06C5ECBBA540

P2093

Q28703551-1F8C67CC-10B1-455A-BC26-AC1BE73938F1

Q28703551-39F9186B-FF4B-42B6-9D74-A9DF27CD830A

Q28703551-44E8A61B-2040-4B9B-AD58-9B2C6AD93E8A

Q28703551-A8459362-DA6E-4F75-9839-B44914631BCB

Q28703551-B4B4CC94-BF33-4A3B-9F8B-DB99B6700864

Q28703551-E3B49735-70B2-4D60-BDE3-B0CCB0B25404

P2860

Q28703551-07377772-9D20-4AEA-A425-2C4CFE7237F5

Q28703551-0BC78882-CE1C-435F-A653-6CBB3DA7137F

Q28703551-0DEEBBFF-96C5-4A27-A20F-639B85520DDB

Q28703551-3F543193-347D-4A4A-A558-C603619376AC

Q28703551-44A664FB-8FE0-47A8-B576-31FD5AF172D5

Q28703551-523B6A74-79A9-42C4-958F-A395FAF47114

Q28703551-5342BEF1-0024-4013-AAC4-AA20072FB396

Q28703551-593ED499-C6E1-4100-8858-C6CF305E4FE2

Q28703551-7DEC1086-810C-4293-8555-D5C1F2867D82

Q28703551-853CE89E-E4FF-4B7B-8883-1E27E0B40777

P304

Q28703551-33DFE7D6-108E-455E-9EBF-D622C3B467BA

P31

Q28703551-54F70DE4-F64C-4341-9722-375F4DFB401F

P3181

Q28703551-5CADB1FE-F0E8-4586-96ED-B20E3818BFF3

P356

Q28703551-8888087E-DBFD-4B87-9DF7-083065D14524

P407

Q28703551-EB3C111B-522A-4F44-83F2-8DD2C3FDFDD4

P433

Q28703551-97523D02-5FD6-485C-B310-3A717664F1CB

P478

Q28703551-D99F5AC9-A2D4-4DAE-8465-C8F29E3A4DE5

P50

Q28703551-8EFF54ED-3295-491B-896E-04103B93E85E

Q28703551-C7953041-8FBF-4D4A-A975-7ED5CF7C5F3C

Q28703551-D988A088-0608-4C17-AED1-794C460BE9FC

P577

Q28703551-60200F08-D96F-4B9A-9BFD-6325E4C7CEA8

P5875

Q28703551-B3C318A3-DA1C-47A0-AC7A-62BFB260D113

P698

Q28703551-B49F74F3-93F1-462B-B4AA-86988639FFEF

P932

Q28703551-4FB7A16B-C83F-42FD-8F7C-827D855A5D16

P3181

P356

P1433

Human Vaccines & Immunotherapeutics

P1476

Meningococcal serogroup Y emergence in Europe: update 2011

@en

P2093

Georgina Tzanakaki

http://www.w3.org/2001/XMLSchema#string

Maija Toropainen

http://www.w3.org/2001/XMLSchema#string

Markku Kuusi

http://www.w3.org/2001/XMLSchema#string

Michael Bröker

http://www.w3.org/2001/XMLSchema#string

Muhamed-Kheir Taha

http://www.w3.org/2001/XMLSchema#string

Susanne Jacobsson

http://www.w3.org/2001/XMLSchema#string

P2860

Whole genome sequencing to investigate the emergence of clonal complex 23 Neisseria meningitidis serogroup Y disease in the United States

Infectious diseases associated with complement deficiencies.

Invasive meningococcal disease in children in Greece: comparison of serogroup A disease with disease caused by other serogroups.

Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005

Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity

Epidemic meningitis, meningococcaemia, and Neisseria meningitidis.

Consensus building and recommendations based on the available epidemiology of meningococcal disease in Gulf Cooperation Council States.

Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies.

Increase of meningococcal serogroup Y cases in Europe: a reason for concern?

Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial.

P304

1907-1911

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3674837

http://www.w3.org/2001/XMLSchema#string

P356

10.4161/HV.21794

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Anna Skoczynska

Maria João Simões

P577

2012-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231861752

http://www.w3.org/2001/XMLSchema#string

P698

23032167

http://www.w3.org/2001/XMLSchema#string

P932

3656084

http://www.w3.org/2001/XMLSchema#string